Icagen reports a smaller loss
                   
newsobserver.com     May 9, 2008          

Icagen reported a smaller first-quarter loss Thursday, as the Durham company cut expenses after ending research studies on a failed treatment for sickle cell disease. ... Icagen continues to study promising treatments for other ailments but is years from winning...               


Add a comment to the article
Type the code shown

Article Analysis:

Related topics:
Companies mentioned:

You might be also interested in the following articles found by Newstin:

Icagen Successfully Completes Phase I Multiple Ascending Dose Clinical Trial of Senicapoc...

yahoo.com     33 mins ago          

Wednesday July 9, 7:30 am ET RESEARCH TRIANGLE PARK, N.C., July 9, 2008 (PRIME NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today reported that the Company successfully completed the Phase I multiple ascending dose clinical trial of...               

analysis/comments

Icagen to Present At the Collins Stewart Fourth Annual Growth Conference On July 10, 2008

primenewswire.com     Jun 26, 2008   1 related          

RESEARCH TRIANGLE PARK, N.C., June 26, 2008 (PRIME NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that executive management will participate in the Collins Stewart Fourth Annual Growth Conference to be held July 8...               

analysis/comments

                   

Drugs made of nicotine

newsobserver.com     Jun 17, 2008   1 related          

Stimulant is key ingredient for tobacco company spinoff Targacep Chemical compounds await testing at Targacept in Winston-Salem. Targacept's experimental drugs look promising, and AstraZeneca and GlaxoSmithKline are investing...               

analysis/comments

                   

Prime Minister Gordon Brown And Rt Hon Dr John Sentamu, Archbishop Of York, Welcome New Standards...

medicalnewstoday.com     4 hrs ago          

The lives of thousands of sickle cell patients in the UK will hopefully be improved following today's launch of the first 'Standards for the Clinical Care of Adults with Sickle Cell Disease', by the Rt Hon Dr John Sentamu, the...               

analysis/comments